Intriguingly, some studies (47, 57) illustrated that a half-life-extended IL-10–Fc can expand terminally exhausted CD8+ tumor-infiltrating lymphocytes (TILs) directly, which means IL-10 may function positively in the anti-tumor process. This evidence concerns the gene CD8A and neoplasm.